Trial · NCT00405067
Results by group30
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 30
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change in LDL-C at 12 Weeks Therapy Compared to Baseline Between Treatments | Combination Therapy | -46.2 | Standard Deviation 23.8 | Percent Change | |
| Percent Change in LDL-C at 12 Weeks Therapy Compared to Baseline Between Treatments | Lomitapide Monotherapy | -29.9 | Standard Deviation 15.3 | Percent Change | |
| Percent Change in LDL-C at 12 Weeks Therapy Compared to Baseline Between Treatments | Ezetimibe Monotherapy | -19.6 | Standard Deviation 9.9 | Percent Change | |
| Percent of Change at 12 Weeks Therapy Compared to Baseline Between Treatments for the Following Parameters: Total Cholesterol (TC) | Combination Therapy | -34.4 | Standard Deviation 18.8 | Percent Change | |
| Percent of Change at 12 Weeks Therapy Compared to Baseline Between Treatments for the Following Parameters: Total Cholesterol (TC) | Lomitapide Monotherapy | -22.8 | Standard Deviation 12.3 | Percent Change | |
| Percent of Change at 12 Weeks Therapy Compared to Baseline Between Treatments for the Following Parameters: Total Cholesterol (TC) | Ezetimibe Monotherapy | -12.0 | Standard Deviation 8.7 | Percent Change | |
| Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) at 12 Weeks as Compared to Baseline. | Combination Therapy | -41.3 | Standard Deviation 22.7 | Percent Change | |
| Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) at 12 Weeks as Compared to Baseline. | Lomitapide Monotherapy | -26.9 | Standard Deviation 14.6 | Percent Change | |
| Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) at 12 Weeks as Compared to Baseline. | Ezetimibe Monotherapy | -17.0 | Standard Deviation 10.5 | Percent Change | |
| Percent Change in Tryglycerides (TGs) at 12 Weeks Compared to Baseline | Combination Therapy | -7.0 | Standard Deviation 36.0 | Percent Change | |
| Percent Change in Tryglycerides (TGs) at 12 Weeks Compared to Baseline | Lomitapide Monotherapy | -5.8 | Standard Deviation 33.6 | Percent Change | |
| Percent Change in Tryglycerides (TGs) at 12 Weeks Compared to Baseline | Ezetimibe Monotherapy | 2.7 | Standard Deviation 35.1 | Percent Change | |
| Percent Change in HDL-C at 12 Weeks Compared to Baseline | Combination Therapy | -9.2 | Standard Deviation 14.4 | Percent Change | |
| Percent Change in HDL-C at 12 Weeks Compared to Baseline | Lomitapide Monotherapy | -6.2 | Standard Deviation 10.8 | Percent Change | |
| Percent Change in HDL-C at 12 Weeks Compared to Baseline | Ezetimibe Monotherapy | 5.9 | Standard Deviation 9.6 | Percent Change | |
| Percent Change in Lipoprotein(a)[Lp(a)]at 12 Weeks as Compared to Baseline | Combination Therapy | -12.0 | Standard Deviation 23.7 | Percent Change | |
| Percent Change in Lipoprotein(a)[Lp(a)]at 12 Weeks as Compared to Baseline | Lomitapide Monotherapy | -11.4 | Standard Deviation 29.1 | Percent Change | |
| Percent Change in Lipoprotein(a)[Lp(a)]at 12 Weeks as Compared to Baseline | Ezetimibe Monotherapy | 7.5 | Standard Deviation 24.1 | Percent Change | |
| Percent Change in Apolipoprotein A1 (Apo A1) at 12 Weeks as Compared to Baseline | Combination Therapy | -10.7 | Standard Deviation 15.8 | Percent Change | |
| Percent Change in Apolipoprotein A1 (Apo A1) at 12 Weeks as Compared to Baseline | Lomitapide Monotherapy | -8.0 | Standard Deviation 12.3 | Percent Change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00405067/results